DEXOLIGO
LIVE

Add to watchlist:

No watchlists yet
View on USPTO

DEXOLIGO Trademark

Serial Number: 79384444 • Registration: 7646613

DEXOLIGO is a trademark filed by Dexcel Pharma Technologies Ltd. on August 2, 2023. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

Dexcel Pharma Technologies Ltd.

1 Dexcel Street
Or Akiva 3060000 , IL

Entity Type: 16

Trademark Details

Filing Date

August 2, 2023

Registration Date

January 14, 2025

Published for Opposition

November 26, 2024

Goods & Services

Pharmaceutical preparations, namely, oligonucleotides, siRNA and antisense RNA for use in the treatment of cancer, hepatitis, neurodegenerative diseases, neurological diseases, hemophilia, complement-mediated disease, hypercholesterolemia, rare genetic diseases, cardio-metabolic diseases, hepatic infectious diseases, rare bleeding disorders, iron overload disorders, hypertriglyceridemia, mixed hyperlipidemia, hypertriglyceridemia, hypertension, preeclampsia, chronic liver infection, anemia, myeloproliferative disorders, auto-immune disorders, chronic kidney diseases, obesity, type 2 diabetes, metabolic syndrome and related conditions, thrombocythemia, gout

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
Aug 15, 2025 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Jul 25, 2025 FICS
FINAL DISPOSITION PROCESSED
Jul 24, 2025 FIMP
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
May 24, 2025 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
May 6, 2025 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
May 6, 2025 OPNR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Apr 15, 2025 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jan 14, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
Jan 14, 2025 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 26, 2024 NPUB
PUBLISHED FOR OPPOSITION
Nov 26, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Nov 20, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 31, 2024 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 16, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 15, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Oct 15, 2024 TROA
REFUSAL PROCESSED BY IB
May 14, 2024 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Apr 24, 2024 RFCS
REFUSAL PROCESSED BY MPU
Apr 24, 2024 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Apr 9, 2024 RFCR
NON-FINAL ACTION WRITTEN
Apr 8, 2024 CNRT
ASSIGNED TO EXAMINER
Apr 3, 2024 DOCK
APPLICATION FILING RECEIPT MAILED
Dec 12, 2023 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 8, 2023 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Dec 7, 2023 REPR